TipRanks
Advertisement
Advertisement

UNCY Stock Latest News

Unicycive Therapeutics: Regulatory Overhang Eases as Oxylanthanum Carbonate Advances; Buy Rating Reiterated with Unchanged $30 Price Target
RatingsUnicycive Therapeutics: Regulatory Overhang Eases as Oxylanthanum Carbonate Advances; Buy Rating Reiterated with Unchanged $30 Price Target
2d ago
UNCY
Unicycive Therapeutics announces FDA acceptance of resubmission of OLC NDA
PremiumThe Fly
Unicycive Therapeutics announces FDA acceptance of resubmission of OLC NDA
4d ago
UNCY
Unicycive Therapeutics appoints Manning to its Board of Directors
PremiumThe Fly
Unicycive Therapeutics appoints Manning to its Board of Directors
24d ago
UNCY
Unicycive Therapeutics price target lowered to $13 from $15 at H.C. Wainwright
PremiumThe Fly
Unicycive Therapeutics price target lowered to $13 from $15 at H.C. Wainwright
25d ago
UNCY
Unicycive Resubmits NDA for Kidney Disease Treatment
PremiumCompany Announcements
Unicycive Resubmits NDA for Kidney Disease Treatment
26d ago
8K
UNCY
Unicycive Therapeutics announces resubmission of NDA for OLC
PremiumThe FlyUnicycive Therapeutics announces resubmission of NDA for OLC
26d ago
UNCY
Unicycive Faces New Securities Class Action Over NDA Disclosures
Premium
Company Announcements
Unicycive Faces New Securities Class Action Over NDA Disclosures
26d ago
8K
UNCY
Unicycive Therapeutics Faces Securities Lawsuit After 39% Stock Plunge Over Repeat FDA Manufacturing Setback
Premium
Class Action
Unicycive Therapeutics Faces Securities Lawsuit After 39% Stock Plunge Over Repeat FDA Manufacturing Setback
1M ago
UNCY
Unicycive Therapeutics Faces Securities Lawsuit After 39% Stock Plunge Over Repeat FDA Manufacturing Setback
PremiumClass Action
Unicycive Therapeutics Faces Securities Lawsuit After 39% Stock Plunge Over Repeat FDA Manufacturing Setback
1M ago
UNCY
Unicycive Therapeutics price target raised to $15 from $13 at Benchmark
PremiumThe Fly
Unicycive Therapeutics price target raised to $15 from $13 at Benchmark
2M ago
UNCY
Analyst Reaffirms Buy Rating on Unicycive, Maintaining 12-Month Price Target at $30 After FDA Procedural Setback
PremiumRatings
Analyst Reaffirms Buy Rating on Unicycive, Maintaining 12-Month Price Target at $30 After FDA Procedural Setback
2M ago
UNCY
Unicycive Therapeutics reports Q2 EPS (6c), consensus (33c)
PremiumThe Fly
Unicycive Therapeutics reports Q2 EPS (6c), consensus (33c)
2M ago
UNCY
Unicycive Therapeutics price target lowered to $20 from $22 at B. Riley
PremiumThe FlyUnicycive Therapeutics price target lowered to $20 from $22 at B. Riley
2M ago
UNCY
Unicycive Therapeutics price target lowered to $25 from $37 at Guggenheim
Premium
The Fly
Unicycive Therapeutics price target lowered to $25 from $37 at Guggenheim
2M ago
UNCY
Unicycive Therapeutics Reports Preliminary Q2 2026 Cash Position
Premium
Company Announcements
Unicycive Therapeutics Reports Preliminary Q2 2026 Cash Position
4M ago
8K
UNCY
Unicycive Therapeutics price target lowered to $50 from $60 at Noble Capital
PremiumThe Fly
Unicycive Therapeutics price target lowered to $50 from $60 at Noble Capital
4M ago
UNCY
Unicycive Therapeutics price target lowered to $13 from $18 at Benchmark
PremiumThe Fly
Unicycive Therapeutics price target lowered to $13 from $18 at Benchmark
4M ago
UNCY
Unicycive Therapeutics price target lowered to $15 from $22 at H.C. Wainwright
PremiumThe Fly
Unicycive Therapeutics price target lowered to $15 from $22 at H.C. Wainwright
4M ago
UNCY
Unicycive Therapeutics CRL tied to same vendor deficiency, says B. Riley
PremiumThe Fly
Unicycive Therapeutics CRL tied to same vendor deficiency, says B. Riley
4M ago
UNCY
Morning Movers: Abivax skyrockets following new obefazimod data
PremiumThe FlyMorning Movers: Abivax skyrockets following new obefazimod data
4M ago
DLR
XYZ
Unicycive Therapeutics receives complete response letter from FDA for OLC NDA
Premium
The Fly
Unicycive Therapeutics receives complete response letter from FDA for OLC NDA
4M ago
UNCY
H.C. Wainwright recommends taking advantage of Unicycive stock weakness
Premium
The Fly
H.C. Wainwright recommends taking advantage of Unicycive stock weakness
4M ago
UNCY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >